Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurocognitive Assessment Platform 4 Alzheimer

NCT07272811 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07272811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07272811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurocognitive Assessment Platform 4 Alzheimer
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2021
Completion date
June 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, amci - amnestic mild cognitive impairment, mci, mci conversion to dementia